These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21655641)

  • 1. Evaluation of proliferation potential in thyroid normo-/hypofunctioning and hyperfunctioning nodules.
    Cornianu M; Stan V; Lazăr E; Dema A; Golu I; Tăban S; Vlad M; Faur A; Vărcuş F; Babău F
    Rom J Morphol Embryol; 2011; 52(2):545-53. PubMed ID: 21655641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cold thyroid nodules show a marked increase in proliferation markers.
    Krohn K; Stricker I; Emmrich P; Paschke R
    Thyroid; 2003 Jun; 13(6):569-75. PubMed ID: 12930601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased thyroid epithelial cell proliferation in toxic thyroid nodules.
    Krohn K; Emmrich P; Ott N; Paschke R
    Thyroid; 1999 Mar; 9(3):241-6. PubMed ID: 10211599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ki-67, PCNA and MPM2 antigens in follicular cells of the thyroid gland after iodotherapy.
    Klim B; Dziecioł J; Litwiejko-Pietryńczak E; Szkudlarek M; Pawlak J; Oniszczuk S; Tobiaszewska D
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():138-9. PubMed ID: 15638400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations in thyroid nodular disease.
    Krohn K; Paschke R
    Mol Genet Metab; 2002 Mar; 75(3):202-8. PubMed ID: 11914031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional activity of human thyrocytes in diffuse toxic goiter, autoimmune thyroiditis and thyroid nodules using nucleolar silver staining].
    Mamaev NN; Grineva EN; Laevskaia ND; Blagosklonnaia IaV
    Arkh Patol; 1994; 56(2):58-62. PubMed ID: 8037597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of an isofunctioning thyroid nodule.
    Hedayati N; McHenry CR
    Am Surg; 2003 Apr; 69(4):311-5; discussion 315-6. PubMed ID: 12716089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
    Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
    Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.
    Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W
    J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
    Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
    Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
    Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
    Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
    Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TV-image analysis based quantification of the proliferative activity and the apoptotic rate in thyroid tumors and thyroiditis.
    Biesterfeld S; Rickert D; Eichler S; Fürste K; Mrusek S; Alfer J
    Anticancer Res; 2003; 23(5b):4269-75. PubMed ID: 14666637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary thyroid nodule in adult Ethiopian patients. Analysis and experience in management in a teaching hospital.
    Mengistu M
    Trop Geogr Med; 1993; 45(3):126-8. PubMed ID: 8362454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer.
    Lyzogubov V; Khozhaenko Y; Usenko V; Antonjuk S; Ovcharenko G; Tikhonkova I; Filonenko V
    Exp Oncol; 2005 Jun; 27(2):141-4. PubMed ID: 15995633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.